In a world that’s always innovating, there’s no shortage of great ideas that can help people live healthier lives. New technologies. Strategies that accelerate the slow development of drugs and vaccines. Novel partnerships that cross continents and sectors. Yet many ideas never get the chance to make an impact—at great human cost.
The journey from idea to real, large-scale solution is complex
Barriers and pitfalls, from regulatory hurdles to deep-seated cultural beliefs, can prevent even the most promising ideas from succeeding. But the odds of success can be greatly increased when those ideas have a creative guide who knows how to navigate the journey—a guide like PATH.
Ideas move through a long and complicated journey before they can have widespread impact.
We call the process of moving from idea to impact the “journey of innovation.” And at every stage, there’s work to be done:
- Adapting a design for low-resource settings.
- Shepherding a new medication through approval.
- Working alongside communities with the will, but not the tools, to protect their children.
- Expanding access to vital care where it’s needed around the world.
It takes tenacity, know-how, and commitment to see the journey through. And that’s where PATH comes in.
In 2012, multiple partners, including PATH, committed to delivering Sayana® Press, a long-acting injectable contraceptive to four countries in Africa in order to increase contraceptive choice and access. Administered in the simple, single-use Uniject™ inj
Nothing should stand in the way of solutions reaching the people who need them most
We believe it’s unacceptable that people around the world continue to be devastated by preventable disease, when we know that innovation can change it. So we identify and cultivate promising ideas that can transform health—and make sure nothing stands in their way. We collaborate with a wide variety of partners, from researchers to manufacturers to local governments as we keep solutions moving toward impact. And we’ve earned a track record of constantly innovating to get those solutions to the people who need them most.
Our partnership with researchers and industry led to a key malaria treatment innovation. Artemisinin, an essential plant-derived ingredient in key malaria medications (ACTs), can now be manufactured with a semisynthetic ingredient in three months, ensurin
We transform the way health solutions are developed and delivered
We’re not afraid of complicated work. And we’re inspired by the partners who travel the journey with us—whether in the laboratory or the factory, in a government hall or the village square.
Behind every innovation, and at every stage in the journey, there are stories to share. Stories of ingenuity, commitment, and compassion. Stories of scientific discovery and of heroes who are changing their families and communities.
This post is part of Mapping the Journey, a multi-part series, which explores how PATH turns ideas into solutions that bring equity, dignity, and health to women, children, and families worldwide.
Sayana® Press is a registered trademark of Pfizer Inc. and/or its affiliates. Uniject™ is a trademark of BD.